Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

57.19 +2.80 (+5.15%)
Streaming Delayed Price Updated: 2:34 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
35 36 Next >
News headline image
Friday Markets Coverage ↗
Today markets are suffering alongside Austria which locked down against Covid-19 again. 
Via Talk Markets
News headline image
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer ↗
The European Commission (EC) has granted conditional marketing authorization to Roche Holdings AG's (OTC: RHHBY) Gavreto (pralsetinib) for treating adults... 
Via Benzinga
News headline image
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar? ↗
Novartis AG (NYSE: NVS) is getting a massive influx of cash from selling its 20-year stake in Roche Holdings AG (OTC: RHHBY), triggering speculation... 
Via Benzinga
News headline image
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes ↗
Spark Therapeutics, a unit of Roche Holdings AG (OTC: RHHBY), has announced data from its Phase 1/2 trial of SPK-8011 in hemophilia A. At a median efficacy follow-up of 33.4... 
Via Benzinga
News headline image
Why Atea Pharmaceuticals Stock Is Sinking Today ↗
Roche calls it quits on the duo's attempt to develop an oral COVID-19 therapy. 
Via The Motley Fool
News headline image
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill ↗
Roche Holdings AG (OTC: RHHBY) has ended a partnership with Atea Pharmaceuticals Inc (NASDAQ: AVIR) to jointly develop a COVID-19 antiviral pill, a month... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill ↗
Roche and Atea's partnership will end in February. 
Via Investor's Business Daily
News headline image
Tuesday Market Overview ↗
While gold gained modestly again today, cryptocurrencies fell hard. 
Via Talk Markets
News headline image
Large Cap Biopharmaceuticals Metrics and Review: JNJ Splits Up ↗
Today JNJ announced a split of the Company separating its legacy consumer products from higher growth growing biopharmaceutical and medtech products. 
Via Talk Markets
News headline image
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail ↗
The European Commission (EC) has approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) COVID-19 antibody cocktail, known as REGEN-COV in the U.S. and... 
Via Benzinga
News headline image
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care ↗
Johnson & Johnson will split its consumer health unit into a publicly traded company. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... 
Via Benzinga
News headline image
Veteran's Day ↗
Stock markets took a tumble today across the board, but not as far down as at the opening. 
Via Talk Markets
News headline image
EU Regulator Backs Regeneron-Roche's COVID-19 Drug ↗
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Regeneron Pharmaceuticals Inc... 
Via Benzinga
News headline image
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters ↗
With already a snail-paced rollout of Biogen Inc's (NASDAQ: BIIB) controversial Alzheimer's treatment Aduhelm, the Company could soon face price competition.... 
Via Benzinga
News headline image
ALX Oncology Falls After Updated Data For Solid Tumors Candidate ↗
ALX Oncology Holdings Inc (NASDAQ: ALXO) released additional data from a phase 1b trial of evorpacept in solid tumor malignancies. One cohort included gastric/... 
Via Benzinga
News headline image
These OTCQX & OTCQB Securities Had the Most Trading Activity in October ↗
Photo by Burak Kebapci from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
News headline image
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose ↗
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has announced additional results from a Phase 3 trial, which assessed a single dose of REGEN-COV (1,200 mg... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
News headline image
The Old Lady Of Threadneedle Street ↗
US markets are up on better jobs growth reported for October today. 
Via Talk Markets
News headline image
Will Pfizer Outgun Merck With Oral COVID-19 Pill? ↗
Merck, Inc. (NYSE: MRK) is locking horns with peer Pfizer, Inc. (NYSE: PFE) in what could be termed as the battle supremacy in the COVID-19 treatment market. The stakes are high,... 
Via Benzinga
News headline image
Thursday Market Overview ↗
If you are an IBM shareholder you now own something new Kyndryl. 
Via Talk Markets
News headline image
7 European Stocks to Buy to Diversify Your Portfolio ↗
While exposure to U.S.-based securities continues to be a good idea, you can diversify your opportunities by considering European stocks. 
Via InvestorPlace
News headline image
Novartis To Offload Its Stake Back To Roche For $20.7B ↗
Novartis AG (NYSE: NVS), a shareholder in Roche Holdings AG (OTC: RHHBY) for more than 20 years, would sell its entire stake, which is nearly one-third voting... 
Via Benzinga
News headline image
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting ↗
Galecto Inc (NASDAQ: GLTO) has entered into a clinical trial supply agreement with Roche Holdings AG (OTC: RHHBY) to explore the combination of GB1211 in... 
Via Benzinga
News headline image
Cyber Currency ↗
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
Via Talk Markets
News headline image
Default Avoided ↗
The Chinese real estate firm Evergrande managed to pay the interest it owes to foreign bondholders. 
Via Talk Markets
News headline image
Why Atea Pharmaceuticals Stock Got Crushed This Week ↗
A mid-stage trial miss caused investors to hit the exits this week. 
Via The Motley Fool
News headline image
FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)
From Genentech
Via Business Wire
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.